CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2905--Medicare IVIG Enhancement Act--Legislation that would create a home infusion benefit under Medicare Part B for intravenous immunoglobulin (IVIG) when used in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). HR 6218, S. 3587--Preserving Patient Access to Home Infusion Act--Allowance of reimbursement for product and administration of durable medical equipment administered drugs (subcutaneous immune globulin specifically) that are listed on self administered drug lists by Medicare contractors. HR 6800--The Heroes Act--Seeking to amend the blood donation awareness program language within the CARES Act to include plasma. Sought provision seeking inclusion of temporary Medicare Part B home infusion during period of national healthy emergency Raising awareness regarding COVID-19 and the potential for convalescent plasma to be used in the creation of a hyper-immune therapy.
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.